Discovering New Therapeutic Targets for Alzheimer’s Disease
Effective therapies for neurodegenerative diseases like Alzheimer’s are urgently needed. But developing new drugs is…
Effective therapies for neurodegenerative diseases like Alzheimer’s are urgently needed. But developing new drugs is…
An Alzheimer’s disease drug developed by AC Immune and Genentech has drawn conflicting phase II…
Muna Therapeutics debuted with the Danish biotech sector’s biggest-ever Series A round earlier this month.…
Scotland has a thriving life sciences ecosystem with strengths in oncology, genetic engineering, and industrial…
The FDA shocked many life sciences observers by greenlighting Biogen’s treatment candidate for Alzheimer’s last…
Paris-based AB Science has scored a rare late-stage clinical triumph in the Alzheimer’s disease field…
For decades, Alzheimer's disease research focused on a hypothesis that has increasingly been contested. A…
An epigenetics drug developed by the Spanish biopharmaceutical company Oryzon has reduced aggressive behavior in…
A deal between Swiss biotech AC Immune and Eli Lilly to develop an oral Alzheimer’s…
A project has launched with a €3.6M grant to treat neurological conditions such as Alzheimer’s…
The German company Vivoryon Therapeutics has raised €43M on Euronext Amsterdam to fund a phase…
AC Immune will receive €27.6M (CHF 30M) from big pharma Eli Lilly as it begins…